Moravek

Moravek, Inc. is a specialist manufacturer and contract development and manufacturing organization providing radiolabeled, stable-labeled, and non-labeled compounds to researchers worldwide. With more than 45 years of experience, the company focuses on custom synthesis and analytical support for pharmaceutical, research, and clinical development needs.

Moravek produces GMP carbon-14-labeled active pharmaceutical ingredients (APIs) for early-phase clinical trials, including synthesis, purification, analysis, and release. Its GMP manufacturing follows ICH Q7 Section 19 guidance, and production takes place in certified ISO Class 7 cleanrooms. The company also offers custom non-GMP compounds labeled with carbon-14, tritium, carbon-13, deuterium, or nitrogen-15, as well as non-labeled compounds. Its catalog includes items such as nucleosides, nucleotides, amino acids, antivirals, and anticancer compounds.

Additional services include radiolabeling, organic synthesis, HPLC and UHPLC, NMR, mass spectrometry, stability studies, quality control and assurance, and long-term storage. Moravek also welcomes quality assurance audits and is licensed to handle DEA Schedule I–V controlled substances.